NCT07238413 Effect of Scapular Stabilization Exercises and ESWT in Patients With Lateral Epicondylitis
| NCT ID | NCT07238413 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Saglik Bilimleri Universitesi |
| Condition | Lateral Epicondylitis |
| Study Type | INTERVENTIONAL |
| Enrollment | 48 participants |
| Start Date | 2025-11-01 |
| Primary Completion | 2026-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 48 participants in total. It began in 2025-11-01 with a primary completion date of 2026-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
We aim to investigate the effects of adding scapular stabilization exercises to the extracorporeal shock wave therapy (ESWT) protocol in the treatment of lateral epicondylitis on pain, muscle strength, functional status, and quality of life.
Eligibility Criteria
Inclusion Criteria: * Aged between 18 and 65 years. * Diagnosed with lateral epicondylitis by a physician, with positive Mill's, Cozen's, or Thomsen tests. * Experiencing pain and tenderness over and around the lateral epicondyle for at least 3 months, with symptoms exacerbated by resisted elbow extension, wrist extension, gripping, and supination. * Willing to voluntarily participate in the study. Exclusion Criteria: * • Individuals with serious systemic or cardiovascular diseases that contraindicate exercise of the hand and upper extremity. * Those diagnosed with upper extremity entrapment neuropathies. * Patients with a diagnosis of malignancy. * Individuals with open wounds on the hand or upper extremity. * Pregnant women or those suspected of being pregnant. * Patients who have received physiotherapy and/or injection treatments within the last 6 weeks. * Patients with diabetes mellitus, rheumatologic diseases, or neurological disorders. * Individuals who have undergone upper extremity surgery or had an upper extremity fracture within the last 6 months. * Patients with coagulation disorders or those receiving anticoagulant therapy. * Individuals with conditions causing degenerative changes in the hand and upper extremity. * Patients diagnosed with carpal tunnel syndrome, cubital tunnel syndrome, thoracic outlet syndrome, medial epicondylitis, radiohumeral bursitis, or cervical disc pathology. * Patients using analgesic or anti-inflammatory medications other than acetaminophen (paracetamol).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07238413 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Lateral Epicondylitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07238413 currently recruiting?
Yes, NCT07238413 is actively recruiting participants. Contact the research team at busracakmakyalcin@gmail.com for enrollment information.
Where is the NCT07238413 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07238413 clinical trial?
NCT07238413 is sponsored by Saglik Bilimleri Universitesi. The trial plans to enroll 48 participants.